Navigation Links
Treatment corrects severe insulin imbalance in animal studies
Date:7/31/2008

Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.

"There is currently no effective medical treatment for children with the most common type of congenital hyperinsulinism," said study leader Diva D. De Len, M.D., a pediatric endocrinologist at The Children's Hospital of Philadelphia. "This type of congenital hyperinsulinism is caused by mutations in genes that encode important potassium channels in the pancreatic beta cells." The study team, from Children's Hospital and the University of Pennsylvania School of Medicine, published their report online on July 17 in the Journal of Biological Chemistry.

In congenital hyperinsulinism (HI), genetic mutations damage the insulin-secreting beta cells in the pancreas. Insulin levels rage out of control and severely reduce blood glucose, a condition called hypoglycemia. If untreated, hypoglycemia may cause irreversible brain damage or death in children. Congenital HI occurs in an estimated one in 50,000 U.S. children, with a somewhat higher incidence among certain groups, such as Ashkenazic Jews.

For the past 20 years, the standard medical treatment for some forms of HI has been the drug diazoxide, which controls insulin secretion by opening up crucial potassium channels in beta cells. However, this drug does not work in the most common and severe forms of HI, in which mutations prevent those channels from forming.

When the abnormal beta cells are confined to a discrete portion of the pancreas, as occurs in approximately half of HI cases, precise surgery on the tiny organ can remove the lesion and cure HI. The Children's Hospital of Philadelphia is a world leader in diagn
'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6050
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Video released of rapid Alzheimers improvement after new immune-based treatment
2. Fertility treatment in developing countries; a cycle of IVF for less than $200
3. New treatment approach promising for lymphoma patients in the developing world
4. Treatment delays result in poor outcomes for men with breast cancer
5. Counting tumor cells in blood predicts treatment benefit in prostate cancer
6. Stroke study reveals key target for improving treatment and suggests that Gleevec may help
7. Hypertension treatment effective in reversing vascular damage
8. Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment
9. Source of drug-tolerant tuberculosis possibly behind TB relapses, intensity of treatment
10. Novel therapeutic strategy for colon cancer treatment
11. New ballast treatment could protect Great Lakes fish

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...with their arboreal hosts. But new research sugges...of choice, the ants can get destructive to neighbo...ember issue of the American Naturalist , is the f...nd it reopens a centuries-old debate on the relati...in species of plants and trees have cozy relations...
(Date:11/5/2009)...ning grant in the amount of $2,756,719 by the Nati...uation Education and Research Training (IGERT) pro...to Kent State. The grant, which is funded under th...runs through 2014. , The grant funds an IGERT pr... sensing (EARS). The purpose of the program is to ...
(Date:11/4/2009)... hold the power to help militaries and munitions m...c waste on test sites. , Compounds known as nitr...rld War II and have been used in military munition...ten used to propel tank shells and act like a more... knowledge of their environmentally harmful effect...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2Switching early breast cancer patients to exemestane improves long term survival 57884 1Switching early breast cancer patients to exemestane improves long term survival 57884 2Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 1Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 2Julio Palmaz to Present at the 2009 TCT Conference 57879 1Julio Palmaz to Present at the 2009 TCT Conference 57879 2
...y Assistance (AOA), a comprehensive, multi-faceted..."cap" on out-of-pocket co-payments for cancer pati...h AOA, patients who are uninsured, underinsured, o...l receive help obtaining financial support for Amg...ng cancer is expensive and our industry needs to f...
...ully so your buddy can get some tail may seem like...rds, it also gives a fascinating peek into hard-wi...hed lizards spend their year on earth looking to r...evolution. An article in the May 9 edition of the ...ovides the first genetic evidence of a trait that ...
...oteins in the brains of individuals addicted to co...nd mechanisms that may one day lead to new treatme...rted in the current issue of Molecular Psychiatry,...mounts of 50 proteins and point to profound change...se, said Scott E. Hemby, Ph.D., of Wake Forest Uni...
Other Biology News:Amgen introduces comprehensive financial assistance programs for cancer patients 2Nice guys do finish first in lizards' evolutionary race 2High-tech research shows cocaine changes proteins and brain function 2
(Date:11/9/2009)... Four of the top 10 pharmaceutical... submissions to Health Canada. Datafarm’s an... 7th Canadian DIA Annual Meeting where Health Cana...panies may submit Hybrid eCTD regulatory submissio... no prior permission request. , ...
(Date:11/9/2009)... Product release is a research ind..., research facilities and research safety study da... Cedar Knolls, NJ (PRWEB) No... today that it has unveiled Pristima™ VM, an...rch facilities that track the use and care of vete...
(Date:11/9/2009)... LONDON, November 9 Following the ...S Food and Drug Administration (FDA), privately,ow...//www.davalinternational.com ) has been informed t...(R) has been awarded an Orphan-Drug,designation fo...ALS). , ALS, also known as Lou Gehrig,s d...
(Date:11/8/2009)...r 6, 2009 As global temperatures and energy costs...l be key to a sustainable future. An attractive ...udies published online in Genome Research ( www....structures of bioethanol-producing microorganisms,... developing new technologies needed to implement p...
Breaking Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2
... closing condition to merger with Raven ...ISCO, Calif., Dec. 20 VaxGen,Inc. (Pink Sheets: V... that,it has, along with Punk Ziegel and Company, ...on stock for quotation on the OTC Bulletin Board, ...the year under the symbol VXGN.,Further, VaxGen an...
...rma is pleased to announce the,fall conference lin...are,impacting the pharmaceutical industry today. T...tional and networking opportunities for Clinical,M... large to small,pharmaceutical, biotech and medica...on some of the featured events and highlights,from...
...Roche has Filed an IND With the US FDA for a ..., August 10 Genmab A/S (OMX: GEN),announced today...al New,Drug application (IND) with the US Food and...ed under the companies, collaboration. Genmab will... not influence Genmab,s,financial guidance for 200...
Other Biology Technology:VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 2VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 3VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board 4Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharma's Fall Line Up! 2Roche Files IND for Second Genmab Antibody 2
Finnpipette BioControl Multichannel, 8 Channel 5-50ul from Thermo Scientific
Acl I (Psp1406 I) from New England Biolabs
Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Acc I from Takara Mirus Bio
Biology Products: